Immix Biopharma (IMMX) Tax Provisions (2021 - 2025)
Immix Biopharma (IMMX) reported Tax Provisions of -$8.3 million for Q4 2025, down 76719.21% on a YoY basis from N/an in Q4 2024, and down 107110.9% sequentially from $7722.0 in Q3 2025.
Immix Biopharma (IMMX) Tax Provisions (2021 - 2025) Analysis & Trends
Immix Biopharma (IMMX) has 5 years of Tax Provisions data on file, last reported at -$8.3 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions fell 76719.21% year-over-year to -$8.3 million; the trailing twelve-month figure through Dec 2025 stood at -$8.2 million (down 20171.94% YoY), and the FY2025 full-year result was -$8.2 million, down 20171.94% from the prior year.
- Tax Provisions slipped to -$8.3 million in Q4 2025, from $7722.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11144.0 in Q3 2024 to a low of -$8.3 million in Q4 2025.
- A 5-year average of -$711749.6 and a median of $3442.5 in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions sank 117995.06% in 2022 and surged 307.12% in 2023, its largest moves.
- Tracing IMMX's Tax Provisions over 5 years: stood at $1477.0 in 2021, then slumped by 117995.06% to -$1.7 million in 2022, then sank by 148.5% to -$4.3 million in 2023, then jumped by 100.25% to $10785.0 in 2024, then slumped by 76719.21% to -$8.3 million in 2025.
- Business Quant data shows IMMX's Tax Provisions at -$8.3 million in Q4 2025, $7722.0 in Q3 2025, and $8914.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immix Biopharma | 473.68 Mn | 473.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.26 Mn |
| Sep 30, 2025 | 7,722.00 |
| Jun 30, 2025 | 8,914.00 |
| Mar 31, 2025 | 9,822.00 |
| Dec 31, 2024 | 10,785.00 |
| Sep 30, 2024 | 11,144.00 |
| Jun 30, 2024 | 10,269.00 |
| Mar 31, 2024 | 8,839.00 |
| Dec 31, 2023 | -4.33 Mn |
| Sep 30, 2023 | 6,807.00 |
| Jun 30, 2023 | 6,349.00 |
| Mar 31, 2023 | 5,170.00 |
| Dec 31, 2022 | -1.74 Mn |
| Sep 30, 2022 | 1,672.00 |
| Jun 30, 2022 | 1,715.00 |
| Mar 31, 2022 | 1,622.00 |
| Dec 31, 2021 | 1,477.00 |
| Sep 30, 2021 | 1,337.00 |
| Jun 30, 2021 | 1,608.00 |
| Mar 31, 2021 | 1,591.00 |